Inventor
Haibing DENG
Inventor
CN
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
Y02PClimate change mitigation technologies in the production or processing of goods13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07HSugars4%
PatentTitleYear
12,351,576FGFR inhibitor, preparation method therefor and application thereof202512,312,353Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents202512,157,755CD73 inhibitor, preparation method therefor and application thereof202411,555,036FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereof202311,420,970Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents202211,312,701Formylpyridine derivative having FGFR4 inhibitory activity, preparation method therefor and use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ABBISKO THERAPEUTICS CO LTD (4)· patent assignee history
2022–2025Patents assigned to NOVARTIS AG (2)· patent assignee history
2022–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBISKO THERAPEUTICS CO LTD | 4 | 2022–2025 |
| NOVARTIS AG | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 6 | 2022–2025 |